SHP099 (Standard)
SHP099 (Standard) is the analytical standard of SHP099. This product is intended for research and analytical applications. SHP099 is an allosteric SHP2 inhibitor, with IC50s of 0.690, 1.241, 0.416, 1.968, 2.896 μM for SHP2, SHP2D61Y, SHP2E69K, SHP2A72V, SHP2E76K. SHP099 inhibits cancer cell growth, such as MV4-11 and TF-1 cell (IC50: 0.32 and 1.73 μM). SHP099 inhibits RAS-ERK signaling and inhibits tumor growth.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 95%
- CAS No.: 1801747-42-1
- Formule: C16H19Cl2N5
- Masse moléculaire:352.26
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-100388
SHP099SHP2 Inhibitor -
HY-136173
BatoprotafibSHP2 Inhibitor -
HY-116009
RMC-4550SHP2 Inhibitor -
HY-18756
NSC-87877SHP PTP Inhibitor -
HY-100463
TPI-1SHP-1 Inhibitor -
HY-137092
IACS-13909SHP2 Inhibitor -
HY-100034
NSC 663284Cdc25 Inhibitor -
HY-10704
PTP1B-IN-1Phosphatase Inhibitor -
HY-15832
GSK 2830371Wip1 Phosphatase Inhibitor -
HY-100462
PTP1B-IN-2PTP1B Inhibitor -
HY-D0886
β-Glycerophosphate disodium salt pentahydratePhosphatase Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1801747-42-1
-
Masse moléculaire 352.26
-
Formule C16H19Cl2N5
-
SMILES
NC1=NC(N2CCC(C)(N)CC2)=CN=C1C3=CC=CC(Cl)=C3Cl
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Chen YN, et al. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature. 2016 Jul 7;535(7610):148-52. [Content Brief]
[2]. Sun X, et al. Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. Leukemia. 2018 May;32(5):1246-1249. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
SHP099 (Standard) Related Classifications
HY-100388R Related Classifications
Powered by Bioz